Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5376
iShares Currency Hedged MSCI Japan ETF
HEWJ
$728M
| $2.64M | ﹤0.01% |
+50,032
| New | +$2.64M |
|
5377
Infosys
INFY
$51B
| $2.64M | ﹤0.01% |
147,932
-1,373,935
| -90% | -$23.8M |
|
5378
PUT
Brown-Forman Class B
BF.B
$13.1B
| $2.63M | ﹤0.01% |
101,100
-86,200
| -46% | -$2.43M |
|
|
TSSI
5379
CALL
TSS Inc
TSSI
$314M
| $2.63M | ﹤0.01% |
372,500
-101,700
| -21% | -$1.31M |
|
5380
PUT
GDS Holdings
GDS
$6.69B
| $2.63M | ﹤0.01% |
75,400
-181,600
| -71% | -$6.28M |
|
5381
Kilroy Realty
KRC
$4.58B
| $2.63M | ﹤0.01% |
70,361
-66,624
| -49% | -$2.72M |
|
5382
Pilgrim's Pride
PPC
$6.65B
| $2.63M | ﹤0.01% |
67,411
-145,943
| -68% | -$5.61M |
|
5383
CALL
PVH
PVH
$4.09B
| $2.63M | ﹤0.01% |
39,200
-52,300
| -57% | -$4.09M |
|
5384
Enterprise Financial Services Corp
EFSC
$2.44B
| $2.62M | ﹤0.01% |
48,607
+4,366
| +10% | +$240K |
|
5385
PUT
Vulcan Materials
VMC
$36.7B
| $2.62M | ﹤0.01% |
9,200
-1,900
| -17% | -$557K |
|
5386
CALL
iShares Global Clean Energy ETF
ICLN
$2.41B
| $2.62M | ﹤0.01% |
159,600
+35,200
| +28% | +$587K |
|
5387
PUT
Lennox International
LII
$15B
| $2.62M | ﹤0.01% |
5,400
-300
| -5% | -$150K |
|
5388
Embecta
EMBC
$227M
| $2.62M | ﹤0.01% |
220,697
+134,402
| +156% | +$1.77M |
|
5389
PUT
CBRE Group
CBRE
$43.7B
| $2.62M | ﹤0.01% |
16,300
-2,800
| -15% | -$440K |
|
5390
CALL
Olema Pharmaceuticals
OLMA
$985M
| $2.62M | ﹤0.01% |
+104,800
| New | +$1.86M |
|
5391
S&T Bancorp
STBA
$1.85B
| $2.62M | ﹤0.01% |
66,510
+22,858
| +52% | +$882K |
|
5392
PUT
Globe Life
GL
$14.3B
| $2.62M | ﹤0.01% |
18,700
-2,100
| -10% | -$284K |
|
5393
PUT
Thomson Reuters
TRI
$44.4B
| $2.61M | ﹤0.01% |
19,494
+2,166
| +13% | +$314K |
|
5394
CALL
Shoals Technologies Group
SHLS
$1.55B
| $2.61M | ﹤0.01% |
307,200
-210,600
| -41% | -$1.89M |
|
5395
PUT
Green Brick Partners
GRBK
$3.1B
| $2.61M | ﹤0.01% |
41,600
+6,800
| +20% | +$448K |
|
5396
First Trust Senior Loan Fund ETF
FTSL
$2.32B
| $2.61M | ﹤0.01% |
56,808
-61,354
| -52% | -$2.81M |
|
5397
ProShares UltraShort Silver
ZSL
$60.1M
| $2.61M | ﹤0.01% |
+48,786
| New | +$5.36M |
|
5398
CALL
BBVA Argentina
BBAR
$3.71B
| $2.6M | ﹤0.01% |
144,000
-24,500
| -15% | -$351K |
|
|
RPC
5399
Ridgepost Capital
RPC
$1B
| $2.6M | ﹤0.01% |
+265,130
| New | +$2.69M |
|
5400
PUT
Manhattan Associates
MANH
$11B
| $2.6M | ﹤0.01% |
15,000
-800
| -5% | -$146K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.